Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionColdstream Capital Management Inc
Latest Disclosed Ownership38,522 shares
Latest Disclosed Value $ 2,336,402
Coldstream Capital Management Inc ownership in BRM / Bristol-Myers Squibb Company

On May 8, 2026 - Coldstream Capital Management Inc filed a 13F-HR form disclosing ownership of 38,522 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $2,019,323 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 32,808 shares of Bristol-Myers Squibb Company. This represents a change in shares of 17.42% during the quarter. The current value of the position is $1,827,291 USD.

Coldstream Capital Management Inc has a history of taking positions in derivatives of the underlying security (BRM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:BRM / Bristol-Myers Squibb Company Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 38,522 5,714 17.42 2,336 32.05 0.0251
2026-02-09 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 32,808 -5,129 -13.52 1,770 3.45 0.0228
2025-11-19 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 37,937 9,329 32.61 1,711 29.15 0.0230
2025-08-12 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 28,608 -6,625 -18.80 1,324 -38.36 0.0217
2025-05-13 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 35,233 -1,054 -2.90 2,149 4.68 0.0458
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 36,287 7,154 24.56 2,052 34.03 0.0437
2024-11-18 2024-09-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 29,133 9,324 47.07 1,532 86.25 0.0331
2024-11-18 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 29,133 1,532
2024-08-07 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 19,809 -348 -1.73 823 -24.79 0.0200
2024-05-14 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 20,157 -1,966 -8.89 1,093 -3.70 0.0278
2024-02-09 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 22,123 -6,370 -22.36 1,135 -31.34 0.0318
2023-11-02 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 28,493 -50,016 -63.71 1,654 -67.07 0.0540
2023-08-03 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 78,509 5,231 7.14 5,021 -1.14 0.1591
2023-05-15 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 73,278 44,530 154.90 5,079 145.55 0.1705
2023-01-10 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 28,748 6,125 27.07 2,068 18.71 0.0757
2022-08-08 2022-06-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 22,623 4,325 23.64 1,742 30.39 0.0679
2022-08-08 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,402 -4,896 1,032 0.0439
2022-05-11 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,298 -262 -1.41 1,336 15.47 0.0460
2022-02-11 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,560 2,484 15.45 1,157 19.40 0.0363
2021-11-12 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,076 2,469 18.15 969 6.60 0.0470
2021-08-16 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,607 -3,688 -21.32 909 -16.76 0.0366
2021-06-16 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,295 688 4.14 1,092 6.02 0.0639
2021-02-16 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,607 3,130 23.22 1,030 26.85 0.0621
2020-11-16 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,477 -157 -1.15 812 1.25 0.0676
2020-08-12 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,634 536 4.09 802 9.86 0.0720
2020-05-27 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,098 -215 -1.61 730 -14.52 0.0798
2020-02-13 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 13,313 4,066 43.97 854 82.48 0.0700
2019-11-15 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 9,247 422 4.78 468 17.00 0.0394
2019-08-15 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 8,825 -1,048 -10.61 400 -15.07 0.0333
2019-05-10 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 9,873 -918 -8.51 471 -16.04 0.0412
2019-02-26 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 10,791 -364 -3.26 561 -19.05 0.0545
2018-11-14 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 11,155 -132 -1.17 693 10.88 0.0628
2018-08-14 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 11,287 -1,189 -9.53 625 -20.89 0.0631
2018-05-15 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 12,476 275 2.25 790 5.61 0.0853
2018-02-14 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 12,201 -1,516 -11.05 748 -14.42 0.0812
2017-11-15 2017-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 13,717 1,062 8.39 874 23.97 0.1017
2017-08-14 2017-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 12,655 680 5.68 705 8.29 0.0909
2017-05-09 2017-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 11,975 360 3.10 651 -4.12 0.0899
2017-02-09 2016-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 11,615 138 1.20 679 9.69 0.1105
2016-11-14 2016-09-30 13F/A-2 BRISTOL MYERS SQUIBB COM 110122108 11,477 -574 -4.76 619 -30.14 0.1097
2016-11-14 2016-09-30 13F/A-1 BRISTOL MYERS SQUIBB COM 110122108 11,477 -574 619 0.1097
2016-11-14 2016-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 11,477 -574 619 0.1097
2016-08-09 2016-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 12,051 -509 -4.05 886 10.47 0.1570
2016-05-16 2016-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 12,560 2,720 27.64 802 18.46 0.1461
2016-02-04 2015-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 9,840 192 1.99 677 18.56 0.1470
2015-11-09 2015-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 9,648 3,128 47.98 571 31.57 0.1526
2015-07-31 2015-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 6,520 891 15.83 434 19.56 0.1135
2015-05-11 2015-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 5,629 -879 -13.51 363 -5.47 0.1000
2015-02-11 2014-12-31 13F Bristol-Myers Squibb COM 110122108 6,508 11 0.17 384 15.32 0.1068
2014-11-13 2014-09-30 13F Bristol-Myers Squibb COM 110122108 6,497 -125 -1.89 333 3.74 0.0946
2014-08-14 2014-06-30 13F Bristol-Myers Squibb COM 110122108 6,622 994 17.66 321 9.93 0.0942
2014-05-07 2014-03-31 13F Bristol-Myers Squibb COM 110122108 5,628 -146 -2.53 292 -4.89 0.0946
2014-02-14 2013-12-31 13F Bristol-Myers Squibb COM 110122108 5,774 -564 -8.90 307 4.78 0.0989
2013-11-07 2013-09-30 13F Bristol-Myers Squibb COM 110122108 6,338 -263 -3.98 293 -0.68 0.0965
2013-08-14 2013-06-30 13F Bristol-Myers Squibb COM 110122108 6,601 6,601 295 0.0997
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-13 2014-09-30 13F Bristol-Myers Squibb COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F Bristol-Myers Squibb COM Call 1,500 73 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.